[PDF][PDF] Quantitative assessment of the association between ABC polymorphisms and osteosarcoma response: a meta-analysis

X Chen, M Jiang, RK Zhao, GH Gu - Asian Pacific Journal of …, 2015 - koreascience.kr
Background: ABC proteins are one key type of transport superfamilies which undertake
majority of drug transport, which affect the osteosarcoma response to chemotherapeutics …

Effect of variation of ABCB1 and ABCC3 genotypes on the survival of bone tumor cases after chemotherapy

J Yang, ZG Wang, HQ Cai, YC Li… - Asian Pacific Journal of …, 2013 - koreascience.kr
We conducted a comprehensive study to investigate the role of genes involved in transport
pathways in response to chemotherapy and clinical outcome of osteosarcoma cases …

Predictive potential of ABCB1, ABCC3, and GSTP1 gene polymorphisms on osteosarcoma survival after chemotherapy

S Liu, Z Yi, M Ling, J Shi, Y Qiu, S Yang - Tumor Biology, 2014 - Springer
Genetic polymorphisms in drug metabolism and transport genes can influence the
pharmacokinetics and pharmacodynamics of chemotherapy drugs. We investigated the role …

The contribution of the ABCG2 C421A polymorphism to cancer susceptibility: a meta-analysis of the current literature

P Chen, L Zhao, P Zou, H Xu, A Lu, P Zhao - BMC cancer, 2012 - Springer
Background ABCG2, also known as BCRP, is a half ATP-binding cassette (ABC) transporter
that localizes to plasma membranes. Recently, a number of studies have investigated the …

[HTML][HTML] ABCB1 (rs1128503) polymorphism and response to chemotherapy in patients with malignant tumors-evidences from a meta-analysis

Z Zhou, Q Chen, D Zuo, H Wang, Y Hua… - International Journal of …, 2015 - ncbi.nlm.nih.gov
Numerous papers have reported ABCB1 polymorphisms are associated with the response
to chemotherapy of cancers. The inconclusive results call for a comprehensive analysis, for …

Effect of ABCB1 and ABCC3 Polymorphisms on Osteosarcoma Survival after Chemotherapy: A Pharmacogenetic Study

D Caronia, A Patino-Garcia, A Peréz-Martínez, G Pita… - PLoS …, 2011 - journals.plos.org
Background Standard treatment for osteosarcoma patients consists of a combination of
cisplatin, adriamycin, and methotrexate before surgical resection of the primary tumour …

[HTML][HTML] Effect of ABCB1 polymorphism on the clinical outcome of osteosarcoma patients after receiving chemotherapy

S Xiaohui, L Aiguo, G Xiaolin, L Ying… - Pakistan Journal of …, 2014 - ncbi.nlm.nih.gov
Objective: To investigate the role of three genetic polymorphisms of ABC proteins in
response to chemotherapy and overall survival of osteosarcoma patients. Methods: A …

[HTML][HTML] Prognostic value of two polymorphisms, rs1045642 and rs1128503, in ABCB1 following taxane-based chemotherapy: a meta-analysis

Q Chen, W Lin, J Yang, M Lin, X Lin… - Asian Pacific Journal …, 2021 - ncbi.nlm.nih.gov
Objective: Genetic polymorphisms can influence the chemotherapeutic response; however,
previous studies have produced conflicting results, and have failed to identify the most …

High expression of ABCG2 is associated with chemotherapy resistance of osteosarcoma

H Shu, B Yuan, Y Huang, L Wang, B He, Q Sun… - Journal of Orthopaedic …, 2021 - Springer
Objectives Previous studies showed overexpression of ABCG2 in a variety of tumor tissues,
which could potentially indicate the probability of chemotherapy resistance. This study …

[PDF][PDF] Effect of variation of ABCB1 and GSTP1 on osteosarcoma survival after chemotherapy

JZ Li, ZQ Tian, SN Jiang, T Feng - Genet Mol Res, 2014 - funpecrp.com.br
We conducted a comprehensive study to investigate the role of genes involved in metabolic
and transport pathways in response to chemotherapy and clinical outcome of osteosarcoma …